Pharma firm Unichem Laboratories today said it has received US regulatory approval for Clonidine Hydrochloride tablets USP used in the treatment of hypertension.

The company has received Abbreviated New Drug Application (ANDA) approval from the United States Food and Drug Administration (USFDA)for the tablets, Unichem Laboratories said in a filing to the BSE.

BSE  |  NSE Price

Also Read   Related Stories News Now - Ranbaxy receives final USFDA approval for Glycopyrolate - India to export fresh litchi to US for first time - After mangoes, India to export litchis to US - Ranbaxy, Aurobindo get USFDA nod for migraine drug - Sun Pharma settles patent dispute with Astra Zeneca - Daiichi wins court battle against Mylan, Matrix

Also Read   Related Stories News Now - Markets flat in opening trades - Oil slides on euro zone, US demand worries - Shriram EPC surges on fund raising plans - Rupee strengthens by 23 paise against dollar to 55.85 - IGL gains ahead of High Court verdict on PNGRB case More

New Ipad Application :Business Standard's all new IPad App Click here to download for free Other Stories      - Markets flat in opening trades - Oil slides on euro zone, US demand worries - Shriram EPC surges on fund raising plans - Rupee strengthens by 23 paise against dollar to 55.85 - IGL gains ahead of High Court verdict on PNGRB case

Tags : Unichem Labs | USFDA | hypertension tablets   Read Business news in  Advertisements -  "Discover The Power of One" -  Help a Child Achieve her. Click to know more -  Benefits Upto Rs. 2.36 Lakhs on the Fully Loaded TJet Petrol. -  Watch The Film Here. Click here to know more.. -  1 billion in saving for Unilever without any tangles. -  A Brand New Server at a Price That Fits Your Budget. Click here -  One Partnership Endless Possibilities. Click here to know more -  Which is the best plan for your daughter -  Check out the TRUE COLOURS of your Stocks, Now for FREE! -  One of the leading business schools in the world.Know More